SecBot SecBot

MNOV

MEDICINOVA INC
Nasdaq· Pharmaceutical Preparations· Inc. DE· CIK 0001226616 Biotech & Drug Discovery
$1.34 −0.06 (−4.29%)
Nov 16 4:00 PM ET · prev $1.40
Market cap
$71.7M
Micro cap
Consensus
Buy
90% Buy or better · 10 analysts
Median target
🔒 Subscribers only
1 year
−5.0%
from $1.41 · Nov 17
30 days
−4.3%
from $1.40
52-week range
$1.23–3.45
−61% from high · low Jun 12
Avg volume 20D
48.8K
Nov 5 spike 139.5K
Short interest
285.2K
≈0.6% of shares · −2.4%
Days to cover
5.4
at average volume
Insider net
−$1.7M
0 buyers · 1 seller · 12 mo
New fund stakes
0
Q3 2026 13F · 0 exits
Filing reports
4
analyzed by SecBot
SecBot read MIXED 6 reports · 90 days
Balance 1 bearish · 1 bullish · 2 mixed · 2 neutral oldest → newest, height = score
Avg score ·High conf. 3/6

Price

Daily candles with volume. Callouts mark insider and congressional trades, rating changes, 13F stakes, reports, catalysts, court and regulator actions, Reddit spikes and short-interest jumps. Hover one for the details (tap on phones).

Signal stack

Where each data set points today.

  • InsidersBEARISH

    1 insider sold $1.7M.

  • InstitutionsMIXED

    Q3 2026: 3 added (0 new), 3 trimmed or exited.

  • AnalystsBULLISH

    9 of 10 rate it Buy or better.

  • Short sellersSTEADY

    Short interest −2.4% to 285.2K shares. 5.4 days to cover, ≈0.6% of shares.

  • TrendDOWNTREND

    25% below its 50-day average.

Who's buying

13F· Q3 2026
0
new positions
0
exits
FundMoveSharesValue
VANGUARD CAPITAL MANAGEMENT LLCDOUBLED3,236,928$5.4M
JANE STREET GROUP, LLCDOUBLED126,987$212.7K
UBS Group AGNEAR_EXIT36,326$60.8K
BARCLAYS PLCTRIM23,735$39.8K
BARCLAYS PLCTRIM42,806$56.5K
SUSQUEHANNA INTERNATIONAL GROUP, LLPTRIM26,752$35.3K
JANE STREET GROUP, LLCNEAR_EXIT15,818$20.9K
BANK OF AMERICA CORP /DE/TRIM13,159$17.4K

Quarterly 13F filings are due 45 days after each quarter ends.

The Street

10 analysts
Buy 90% rate it Buy or better
Strong Buy2Buy7Hold1Sell0Strong Sell0

Fresh Price Targets

Analyst price targets updated within the last 24 hours are for subscribers only.

Subscribe for Full Access
Recent actions
DateFirmActionRating
Sep 17, 2026Roth Capital
INITIATE
INITIATEBuy

Insider ledger

Form 4
$0
bought · 0 insiders
$1.7M
sold · 1 insider
DateInsiderTypeValue
Sep 25, 2026
3D Investment Partners Pte. Ltd.
Sep 25, 2026
SELL$1.7M
Jun 23, 2026
Lemerond Nicole
Director
Jun 23, 2026
AWARD44,500 sh
Jun 23, 2026
BEAVER CAROLYN
Director
Jun 23, 2026
AWARD44,500 sh
Jun 23, 2026
Nagao Hideki
Director
Jun 23, 2026
AWARD44,500 sh

Earnings setup

Estimates

Revision history: 🔒 Fresh data, subscribers only

PeriodEPS est.Range30D rev.Revenue
Current Q🔒 Fresh data, subscribers only
Next Q-$0.08-$0.08–-$0.08No data$0.00
Current FY🔒 Fresh data, subscribers only
Next FY🔒 Fresh data, subscribers only

Short side

FINRA· Oct 30, 2026
285,184
shares short
-2.4%
vs prior settlement
5.4
days to cover
≈0.6%
of shares outstanding
Trading halts
Sep 18, 2026Volatility PauseResumed
Recent activity
The latest filings, insider trades, analyst actions, press and options flow, newest first.
Nov 16, 2026 SEC
🔒 Fresh report (last 24h), subscribers only
Nov 11, 2026 Earnings calendar
MNOV Q3 2026 Earnings Scheduled · 2026-11-11
Oct 30, 2026 SEC
Vanguard Capital Management LLC disclosed a 7.20% passive stake in MediciNova Inc via Schedule 13G, with the Vanguard…
SC 13G · Impact 3/10
Sep 30, 2026 Inst.
VANGUARD CAPITAL MANAGEMENT LLC · DOUBLED
3,236,928 shares ($5.4M)
Sep 30, 2026 Inst.
JANE STREET GROUP, LLC · DOUBLED
126,987 shares ($212.7K)
Sep 28, 2026 Press
MediciNova reported Phase 2 topline results for MN-001 (tipelukast) in hypertriglyceridemia and NAFLD with T2DM. The…
Impact 5/10
Sep 25, 2026 Insider
3D Investment Partners Pte. Ltd. sold 640,000 shares
$2.70 ($1.7M)
Sep 24, 2026 Press
MediciNova announced completion of the last patient's final visit in the double-blind portion of its Phase 2b/3…
Impact 7/10
Catalysts
Scheduled dates and disclosed events: earnings, FDA and trial readouts, halts, press releases. Colored dot = impact.
Recent

SecBot reports

4 filings · 2 press releases · 1 bullish · 1 bearish · 2 neutral
All MNOV filing & press-release reports (6)